More and more Americans on-the-go are skipping the “most important meal of the day,” not eating until lunch… This tendency to miss breakfast has already been linked to the growing epidemic of obesity and cardiovascular problems in the U.S. — and it may put the health of diabetics at risk …
Read More »Men With Erectile Dysfunction Should Be Tested For Diabetes
1 in 10 men between the ages of 40 and 59 reporting ED had undiagnosed diabetes in a recent study… Results of a recent study indicate that erectile dysfunction, particularly in middle-aged men, may be a strong indicator of diabetes. The findings highlight the importance for providers to screen any …
Read More »Stem Cells Reduce A1c
Rexlemestrocel-L (mesoblast) can reduce A1c after a single intravenous infusion…
Read More »Auvi-Q
Auvi-Q (epinephrine injection, USP) is used to treat life-threatening allergic reactions (anaphylaxis) in people who are at risk for or have a history of these reactions. The first and only compact epinephrine auto‑injector for severe allergic reactions that talks you through the injection process step by step. It comes in …
Read More »Discussion of Practical Implementation of SGLT-2’s with a Patient, Part 3
In this week’s Homerun Slides, we continue our short series on introducing SGLT-2 inhibitor therapy to your patients. Topics this week include: Practical Clinical Approaches To Maximize Benefits and Minimize Risks… To download the complete set in PowerPoint format, just use this link: Discussion of Practical Implementation of SGLT-2’s with a Patient, …
Read More »Glucagon Patch Info
Two Gene Mutations Identified in Increased Risk of Obesity and Diabetes
Mutations in the ankyrin-B gene cause fat cells to soak up more glucose, setting the stage for obesity and insulin resistance… Ankyrin-B was discovered more than 30 years ago by researcher Vann Bennett at Duke University School of Medicine and the Howard Hughes Medical Institute. The gene plays a role …
Read More »Liver Disease Affects Metformin Metabolism
Increased diabetes drug exposure may increase risk of adverse reactions in type 2 patients with NASH… Obesity increases the risk of nonalcoholic steatohepatitis (NASH), which occurs when there is too much fat in the liver. NASH is often asymptomatic and because testing for it requires a liver biopsy, many cases …
Read More »Bromocriptine for High Dose Insulin Therapy Type 2 Patients
Treatment can decrease amount of total daily insulin dose due to insulin sensitizer properties… As the duration of diabetes diagnosis lengthens for patients, management of the disease gets more difficult. Insulin therapy is very effective in treating hyperglycemic events, however it carries unwanted side effects such as hypoglycemia and weight …
Read More »Diabetes Drug May Protect Against Parkinson’s Disease
Glitazone antidiabetes drugs found to decrease incidence of disease…
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.